Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Endocrine Development
|
December 20, 2015
C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia
Laurence Legeai-Mallet
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Hereditary multiple exostoses and enchondromatosis
Stéphanie Pannier, Laurence Legeai-Mallet
Biochimica Et Biophysica Acta
|
February 27, 2007
FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation
Linda Gibbs, Laurence Legeai-Mallet
Bone
|
August 16, 2020
Novel therapeutic approaches for the treatment of achondroplasia
Laurence Legeai-Mallet, Ravi Savarirayan
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
December 18, 2016
Achondroplasia: Development, pathogenesis, and therapy
David M Ornitz, Laurence Legeai-Mallet
Journal of Visualized Experiments : Jove
|
October 14, 2024
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Anne Morice, Emilie Panafieu, Amélie De la Seiglière, et al.
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Achondroplasia
Geneviève Baujat, Laurence Legeai-Mallet, Georges Finidori, et al.
Disease Models & Mechanisms
|
March 19, 2021
An Fgfr3-activating mutation in immature murine osteoblasts affects the appendicular and craniofacial skeleton
Martin Biosse Duplan, Emilie Dambroise, Valentin Estibals, et al.
FEBS Letters
|
May 18, 2007
Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: an in vitro model to study chondrodysplasias
Catherine Benoist-Lasselin, Linda Gibbs, Solange Heuertz, et al.
The American Journal of Pathology
|
October 9, 2002
Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations
Sarah Cormier, Anne-Lise Delezoide, Catherine Benoist-Lasselin, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Endocrine Development
|
December 20, 2015
C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia
Laurence Legeai-Mallet
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Hereditary multiple exostoses and enchondromatosis
Stéphanie Pannier, Laurence Legeai-Mallet
Biochimica Et Biophysica Acta
|
February 27, 2007
FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation
Linda Gibbs, Laurence Legeai-Mallet
Bone
|
August 16, 2020
Novel therapeutic approaches for the treatment of achondroplasia
Laurence Legeai-Mallet, Ravi Savarirayan
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
December 18, 2016
Achondroplasia: Development, pathogenesis, and therapy
David M Ornitz, Laurence Legeai-Mallet
Journal of Visualized Experiments : Jove
|
October 14, 2024
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Anne Morice, Emilie Panafieu, Amélie De la Seiglière, et al.
Best Practice & Research. Clinical Rheumatology
|
March 11, 2008
Achondroplasia
Geneviève Baujat, Laurence Legeai-Mallet, Georges Finidori, et al.
Disease Models & Mechanisms
|
March 19, 2021
An Fgfr3-activating mutation in immature murine osteoblasts affects the appendicular and craniofacial skeleton
Martin Biosse Duplan, Emilie Dambroise, Valentin Estibals, et al.
FEBS Letters
|
May 18, 2007
Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: an in vitro model to study chondrodysplasias
Catherine Benoist-Lasselin, Linda Gibbs, Solange Heuertz, et al.
The American Journal of Pathology
|
October 9, 2002
Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations
Sarah Cormier, Anne-Lise Delezoide, Catherine Benoist-Lasselin, et al.
Page
of 6